Healthcare Services

Crohn’s disease treatment market insights highlighting opportunities

April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Crohn’s Disease (CD) Treatment Market Compare Between 2026 And 2030?

The crohn’s disease (cd) treatment market size has seen consistent growth over recent years. Its valuation is anticipated to rise from $12.32 billion in 2025 to $12.88 billion in 2026, advancing at a compound annual growth rate (CAGR) of 4.5%. The expansion observed in prior periods stemmed from factors including the increasing prevalence of inflammatory bowel disease, the recognized limitations of conventional corticosteroids, a management approach centered on hospitals, persistent delayed diagnosis rates, and a significant reliance on immunomodulators.

The crohn’s disease (cd) treatment market size is projected to experience substantial expansion over the next few years. It is forecast to grow to $16.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.6%. This expected growth can be attributed to advancements in biologics development, the proliferation of precision medicine, increased patient awareness, refined diagnostic techniques, and enhanced specialty gastroenterology care. Prominent trends anticipated in this period include the rising utilization of biologic therapies, the expansion of targeted small molecule drugs, a heightened focus on achieving long-term disease remission, the development of personalized treatment approaches, and the integration of combination therapy regimens.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Which Key Factors Are Driving The Crohn’s Disease (CD) Treatment Market Growth?

The future expansion of the Crohn’s disease (CD) treatment market is anticipated due to the rising occurrence of inflammatory bowel diseases. Inflammatory bowel disease (IBD) encompasses a range of persistent inflammatory conditions predominantly impacting the gastrointestinal (GI) system. Treatment for Crohn’s disease (CD) provides symptom alleviation, diminishes inflammation, fosters disease remission, and improves the overall well-being of those affected by chronic inflammatory bowel disease. As an illustration, a September 2023 assessment by the United States National Library of Medicine, a medical library located in the US, determined that in Canada, the incidence of inflammatory bowel diseases (IBD) stood at an estimated 30 per 100,000 person years in 2023, with forecasts showing a consistent annual rise of around 0.58% per year. By 2023, the widespread occurrence of IBD in Canada had reached approximately 825 per 100,000, and predictions indicate a potential increase to 1.1% of the population by 2035. Consequently, the growing prevalence of inflammatory bowel diseases is a key factor propelling the Crohn’s disease (CD) treatment market.

How Are Different Segments Classified In The Crohn’s Disease (CD) Treatment Market Segment Analysis?

The crohn’s disease (cd) treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types

2) By Route Of Administration: Oral, Injectable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Antibiotics: Metronidazole, Ciprofloxacin, Rifaximin

2) By Amino Salicylates: Mesalamine, Sulfasalazine

3) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

4) By Immunomodulators: Azathioprine, Mercaptopurine, Methotrexate

5) By Other Drug Types: Biologic Therapies, Janus Kinase Inhibitors, Small Molecules

Which Trends Are Guiding The Direction Of The Crohn’s Disease (CD) Treatment Market?

Major companies operating within the Crohn’s disease (CD) treatment market are prioritizing the creation of advanced technologies, such as non-invasive biomarker-based diagnostic platforms, to improve disease detection, boost monitoring accuracy, and support individualized treatment decisions. Non-invasive diagnostic technologies for Crohn’s disease encompass tools that examine biological samples without requiring intrusive procedures, thereby allowing for earlier identification of inflammation, better tracking of disease activity, and an enhanced patient experience. For example, in March 2023, The IRR Chemistry Hub, an interdisciplinary research center based in Scotland, unveiled IBDSENSE, a fluorescence-based technology developed to enhance the diagnosis and monitoring of inflammatory bowel disease, which includes Crohn’s disease. The platform measures the enzyme activity of Granzyme B (GzmB) in patient biosamples, offering a patient-friendly, non-invasive method to assess disease progression and inform therapeutic choices.

Who Are The Companies Driving Activity In The Crohn’s Disease (CD) Treatment Market?

Major companies operating in the crohn’s disease (cd) treatment market are AbbVie Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Amgen Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Ferring B.V., Eli Lilly and Company, Sanofi S.A., Bristol-Myers Squibb Company, Galapagos NV, Abivax, Biogen Inc., Gilead Sciences, RedHill Biopharma, Prometheus Biosciences, Hoffmann-La Roche

Get The Full Crohn’s Disease (CD) Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Which Region Leads The Crohn’s Disease (CD) Treatment Market In Terms Of Market Share?

North America was the largest region in the Crohn’s disease (CD) treatment market in 2025. The regions covered in the crohn’s disease (cd) treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Crohn’s Disease (CD) Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Browse Through More Reports Similar to the Global Crohn’s Disease (CD) Treatment Market 2026, By The Business Research Company

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795